Global Ursolic Acid Market - Strategic Insights and Forecasts (2026-2031)

The global Ursolic Acid Market is forecast to grow at a CAGR of 6.1%, reaching USD 6.84 billion in 2031 from USD 5.08 billion in 2026.

Ursolic Acid is a compound of triterpene acid found in various plants, such as prunes, hawthorn, thyme, oregano, lavender, cranberries, apples, and many others. This generic acid has many nutritious health-enhancing properties, such as antioxidant, anti-fungal, anti-bacterial, and anti-inflammatory properties, among others.

Various research and studies have been conducted to develop Ursolic acid extracts and incorporate these extracts into different food products and for pharmaceutical purposes. Thus, it could be rationally predicted that the inclusion of ursolic acid would be a well-warranted and effective nutrient provision to alleviate age-related dysregulation and changes in body composition. It is also an anti-depressant and can stimulate the synthesis of tortuous structures in humans' skin.

Ursolic Acid Market Growth Drivers:

• The growing adoption of healthy lifestyles is anticipated to expand the global ursolic acid market.

Ursolic acid is highly valued for its wide range of health benefits, particularly in addressing cardiovascular diseases, diabetes, obesity, and cancer. It reduces blood and serum cholesterol levels, decreases the incidence of stroke and heart attack, and lowers blood pressure . According to the World Health Organization’s July 2025 update, cardiovascular diseases remained the world’s leading cause of death, with an estimated 19.8 million deaths in 2022, accounting for approximately 32% of all global deaths, while 85% of these deaths were attributable to heart attacks and strokes. WHO also identifies population ageing, obesity, physical inactivity, unhealthy diets, elevated blood pressure, high blood glucose, and abnormal blood lipids as important contributors to cardiovascular risk. Consequently, continued research into naturally derived compounds such as ursolic acid is supported by the growing need for approaches targeting metabolic and cardiovascular risk factors. However, most evidence for ursolic acid’s therapeutic effects remains preclinical, and further clinical research is required to establish its efficacy and safety for human disease management.

These factors will also lead to increased consumption of ursolic acid globally during the forecasted period. Furthermore, it can enhance the action of insulin and help in better diabetic management by improving glucose metabolism while helping to reduce weight. It even fights against tumors and their spread in the body. The increasing prevalence of lifestyle ailments worldwide and rising consumer interest in natural products are expected to stimulate the ursolic acid market’s growth.

Furthermore, it is expected that by 2030, the global diabetes-afflicted population will be 643 million, according to the IDF figures. It is estimated to rise to 783 million by 2045. The increase in diabetic diseases is also a factor driving the global ursolic acid market’s growth. This acid can potentially treat diabetes by enhancing insulin resistance and lowering blood sugar levels. As a rising number of people tend to go for natural cures and medicinal plants, ursolic acid is becoming common over time, attributed to its therapeutic effects.

• Growing R&D expenditure on various formulations of ursolic acid is anticipated to expand the market.

The active property of Ursolic Acid is also known for encouraging healthy body mass. This development has resulted in the quick expansion of resistant starch-bearing capsules and muscular development and weight reduction supplements. As a result, health-conscious and fitness-enthusiastic individuals are buying supplements and products enriched with ursolic acid. Moreover, the potential for this market among athletes and sportspersons appears significant, as there will likely be high demand in the coming years. So, the manufacturers and producers have been expanding their product lines and distribution channels to this market. There has been an increase in the income generated from the online and e-commerce earned income sectors, which will be dominant in the years to come.

Consequently, an increasing amount of ursolic capsules are being sold since they offer several health advantages. For instance, cardiovascular diseases are prevalent in many people, which has led to an increased demand for ursolic acid capsules. Growing numbers of firms have been investing in their capabilities to manufacture and produce such capsules without limiting themselves to any particular functions. The nutrition and health industries have several sectors aligning with the pharmaceutical industry, which is one of the determining factors in the global ursolic acid market’s expansion.

• The emergence of nanotechnology-based ursolic acid nanoparticles is one of the major factors contributing to the market growth.

The global requirement for products and services based on ursolic acid nanoparticles possesses a relatively high growth potential. This is due to technological advancement; nanoparticles have been changing the market in all sectors and industries. Nanoparticles are used in aviation, medicine, pharmaceuticals, and other sectors. Nanoparticles of ursolic acid drugs are also pivotal in changing the landscape of the pharmaceutical sector.

Using nanocapsules composed of the ursolic acid guard to treat cancerous cells is a new approach. This is being researched by major facilitation and research centers using the compound to address cancer and related issues. It has been observed that nanoparticles of ursolic acid are capable of killing melanoma cell population, and their efficacy is very much time dependent. The findings from the research carried out by Frontiers in July 2024 on the efficacy of treating the risk of gastrointestinal cancer with ursolic acid indicate the need for more effective approaches, such as molecular profiling and drug delivery using nanoparticles for the management of GI cancers.

Those tentative studies will be the new advance in drug-making processes and perhaps the new treatment focus in the next few years. The medical market is expected to play a significant factor in the ursolic acid market's overall expansion, as the anti-diabetic and anti-inflammatory effects of this compound. It is also a potential anticancer drug that will promote the demand for its research during the forecasted period. With advancements and technical innovations in the pharmaceutical field, ursolic acid nanoparticles will register major growth in the coming years.

• Apple pomace generated during its production offers a valuable resource for extracting and utilizing this beneficial ursolic acid.

Juice Industrial Waste is being used to develop bioactive compounds. Apple juice has numerous health-promoting properties, and the apple pomace generated during production is a valuable source of ursolic acid.  It is used to support hydration, contains beneficial plant compounds such as polyphenols, supports heart health, and helps in enhancing brain-related properties. Apples peels contain a significant amount of ursolic acid, and their waste is used to develop bioactive compounds. Apple waste is also known as a by-product of the beverage industry. The raw materials are comparatively cheaper, and the major drawback is that there is no proper or robust industrial use of raw materials and waste products. The waste products contain a high nutrient source that is beneficial for the human body.

Therefore, major companies in the ursolic acid market have been working and trying to capitalize on the opportunity to use huge amounts of apple waste to develop various types of bioactive compounds. Other fruits such as rosemary, cranberry, and orange peels are also rich in ursolic acid. Fruit is an essential commodity, and its consumption will also surge with the growing population globally. For this reason, there is a need to develop proper extraction mechanisms and techniques to utilize industrial and agricultural waste in the form of orange peels and apple pomace.

Ursolic Acid Market Key Development:

• June 2026: NorthStrive Biosciences filed two U.S. patent applications covering muscle-preservation approaches involving EL-22 and EL-32, including combinations with ursolic acid for obesity-related weight-loss applications.

• April 2026: GRANDEVITY officially launched Longevity Synergy, a plant-based supplement containing ursolic acid alongside resveratrol, green tea, rosemary and other botanical ingredients targeting healthy aging.

• January 2026: Emmyon announced the commercial launch of Virbac’s URSOLYX™ Soft Chews for Cats, confirming commercialization of its ursolic acid technology for feline muscle-health supplementation.

• January 2026: Virbac launched URSOLYX™ Soft Chews for Cats, extending its ursolic-acid-based muscle-support technology into feline health following the canine product launch in 2025.

List of Top Ursolic Acid Companies:

• Sami-Sabinsa group

• Changsha Staherb Natural Ingredients

• Run Shaanxi Days of Bio-tech

• Shaanxi Huike Botanical Development

• Changsha Luyuan Bio-Tech

Ursolic Acid Market Scope: